Stay updated on Atezolizumab vs Durvalumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page.

Latest updates to the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page
- Check4 days agoChange DetectedThe web page has been updated to reflect a decrease in the number of study locations from 199 to 178, with significant additions of new locations in various countries, including the United States, Brazil, China, and several European nations.SummaryDifference28%
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.7%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.7%
- Check39 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.0%
- Check54 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check61 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
Stay in the know with updates to Atezolizumab vs Durvalumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page.